Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplastic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05180422
What this trial is testing

A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis

Who this might be right for
Non Small Cell Lung Cancer
Criterium, Inc.
Early research (Phase 1)Study completedNCT01322802
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer

Who this might be right for
Stage III Ovarian Epithelial CancerStage III Ovarian Germ Cell TumorStage IV Ovarian Epithelial Cancer+1 more
University of Washington 25
Testing effectiveness (Phase 2)Study completedNCT00108953
What this trial is testing

A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Bayer 96
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07142837
What this trial is testing

Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 153
Testing effectiveness (Phase 2)Study completedNCT02303977
What this trial is testing

Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy

Who this might be right for
Patients With Stage IV or Recurrent Adenocarcinoma of the Lung
Abramson Cancer Center at Penn Medicine 37
Testing effectiveness (Phase 2)Study completedNCT03611712
What this trial is testing

PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer

Who this might be right for
Cancer-related FatigueSurvivalTumor, Esophageal
PhytoHealth Corporation 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT07338981
What this trial is testing

The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.

Who this might be right for
Advanced Kidney Cancer
Guliz Ozgun 142
Early research (Phase 1)Not Yet RecruitingNCT07482319
What this trial is testing

A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumors
Beijing Geekgene Technology Co., LTD 15
Early research (Phase 1)Looking for participantsNCT07107230
What this trial is testing

JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

Who this might be right for
Advanced Stage Solid Tumors
Janssen Research & Development, LLC 400
Early research (Phase 1)Active Not RecruitingNCT06883630
What this trial is testing

A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
RemeGen Co., Ltd. 121
Testing effectiveness (Phase 2)WithdrawnNCT07060365
What this trial is testing

A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer

Who this might be right for
Advanced/Recurrent Ovarian Cancer
AstraZeneca
Testing effectiveness (Phase 2)Study completedNCT00054054
What this trial is testing

S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT05101629
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 32
Early research (Phase 1)UnknownNCT05136937
What this trial is testing

A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorAdvanced Cancer
Wuxi People's Hospital 18
Early research (Phase 1)Not Yet RecruitingNCT06823245
What this trial is testing

Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Advanced Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 32
Early research (Phase 1)WithdrawnNCT00939172
What this trial is testing

TTP607 in Refractory Solid Malignancies

Who this might be right for
Advanced CancersLymphoma
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT06130995
What this trial is testing

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Who this might be right for
Androgen Deprivation TherapyLocally Advanced Prostate Cancer
University of Oklahoma 46
Not applicableUnknownNCT03919539
What this trial is testing

Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab

Who this might be right for
Drug Resistance to Famitinib and CamrelizumabBiomarkers for Efficacy and Toxicity
Peking University People's Hospital 40
Early research (Phase 1)Ended earlyNCT03816839
What this trial is testing

Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)

Who this might be right for
Breast Cancer
Sanofi 10
Testing effectiveness (Phase 2)Study completedNCT03843775
What this trial is testing

Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers

Who this might be right for
Advanced BRAF Mutant Cancers
Memorial Sloan Kettering Cancer Center 17
Next Page